Senescence Model Theories from In Vitro through In Vivo

No Thumbnail Available

Date

2024

Journal Title

Journal ISSN

Volume Title

Publisher

Duzce University Medical School

Access Rights

info:eu-repo/semantics/openAccess

Abstract

The theoretical equivalence of expressing that a cell is aging to its inability to perform the assumed function is not exactly accurate, it involves a gradual decrease in cell aging mechanisms. Factors such as genetics, lifestyle, and environmental effects maintain the biological change of the cell. The concept of cellular senescence was initially introduced by Hayflick and his collaborators in 1961 when they noticed that human diploid fibroblasts cultured in vitro could undergo only a limited number of cell divisions before their ability to proliferate was permanently halted. This phenomenon, known as the 'Hayflick limit', was subsequently linked to the gradual shortening of telomeres with each successive round of cell division. Throughout the aging process, senescent cells collect in different tissues. Their involvement in age-related health issues such as neurodegenerative disorders, heart problems, cancer, kidney-related changes, chronic lung diseases, and osteoarthritis suggests that targeting senescent cells therapeutically could be promising across various health conditions. This review will discuss the available data on which cell types may undergo aging based on biological aging and how these processes may impact age-associated tissue-specific pathologies. Additionally, the markers used to characterize the physiological transition of aging cells from in vitro to in vivo settings will be evaluated. The discussed data may serve as a significant starting point for an expanded definition of the molecular and functional characteristics of aging cells in different organs, thus supporting the development and enhancement of targeting strategies in vivo. © 2024, Duzce University Medical School. All rights reserved.

Description

Keywords

biological aging mechanism, Cell senescence, cellular aging theories, geriatric in vivo models, aging, cell aging, cell division, chronic lung disease, diploidy, drug therapy, fibroblast, human, human cell, in vitro study, kidney cancer, nonhuman, osteoarthritis, pharmacology, review, senescence, telomere

Journal or Series

Düzce Tıp Fakültesi Dergisi

WoS Q Value

Scopus Q Value

Q4

Volume

26

Issue

S1

Citation